Table 1.
Compound | Sequence |
---|---|
TAT | (d)1-Ac-RKKRR-Orn-RRR-COOH |
NLS | Ac-KKKRKV-COOH |
TAT-BH4 | (d)1-Ac-RKKRR-Orn-RRR-β-A-(l)1-SNRELVVDFLSYKLSQKGYS-COOH |
TAT-BH4i | (d)1-Ac-RKKRR-Orn-RRR-β-A-(l)1-SNRELVVDFLSDKLSQKGDS-COOH |
NLS-BH4 | Ac-KKKRKV-β-A-(l)1-SNRELVVDFLSYKLSQKGYS-COOH |
NLS-BH4i | Ac-KKKRKV-β-A-(l)1-SNRELVVDFLSDKLSQKGDS-COOH |
FITC-TAT-BH4 | (d)1-Ac-C(FM) RKKRR-Orn-RRR-β-A-(l)1-SNRELVVDFLSYKLSQKGYS-COOH |
FITC-NLS-BH4 | (d)1-Ac-C(FM) KKKRKV-β-A-(l)1-SNRELVVDFLSYKLSQKGYS-COOH |
(d) indicates that the subsequent amino acids are D-amino acids while (l) indicates that the subsequent amino acids are L-amino acids. Unmarked sequences are composed entirely of L-amino acids.